Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

artesunate 50mg + amodiaquine 153.1mg

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

artesunate 50mg + amodiaquine 153.1mg

United States - English - NLM (National Library of Medicine)

sti pharma llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline hyclate is indicated for use as an adjunct to scaling and root planing to promote attachment level gain and to reduce pocket depth in patients with adult periodontitis. to reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in persons who have shown hypersensitivity to doxycycline or any of the other tetracyclines.

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 20 mg - doxycycline hyclate tablets are indicated for use as an adjunct to scaling and root planing to promote attachment level gain and to reduce pocket depth in patients with adult periodontitis. to reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, usp and other antibacterial drugs, doxycycline hyclate tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in persons who have shown hypersensitivity to doxycycline or any of the other tetracyclines.

United States - English - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline hyclate tablets  are  indicated for use as an adjunct to scaling and root planing to promote attachment level gain and to reduce pocket depth in patients with adult periodontitis. this drug is contraindicated in persons who have shown hypersensitivity to doxycycline or any of the other tetracyclines.

Singapore - English - HSA (Health Sciences Authority)

smith & nephew pte. limited - general & plastic surgery - is intended for use with the arthrocare system 2000 for ablation, coagulation, and decompression of disc material to treat symptomatic patients with contained herniated discs

Singapore - English - HSA (Health Sciences Authority)

humedical (s) pte. ltd. - general & plastic surgery - intended for use with the system 2000 for ablation, coagulation, and decompression of disc material to treat symptomatic patients with contained herniated discs.

Canada - English - Health Canada

nt pharma canada ltd - risedronate sodium (risedronate sodium monohydrate) - tablet - 5mg - risedronate sodium (risedronate sodium monohydrate) 5mg - bone resorption inhibitors

Canada - English - Health Canada

nt pharma canada ltd - risedronate sodium (risedronate sodium monohydrate) - tablet - 30mg - risedronate sodium (risedronate sodium monohydrate) 30mg - bone resorption inhibitors

Canada - English - Health Canada

nt pharma canada ltd - risedronate sodium (risedronate sodium monohydrate) - tablet - 35mg - risedronate sodium (risedronate sodium monohydrate) 35mg - bone resorption inhibitors